Clayton PA, Aouad L, Wyburn KR, Eris JM, Chadban SJ. HbA1c is insensitive at month 3 after kidney transplantation. Transplantation. 2015;99(5):e37-e8.
Author: admin
Filter
Campbell S, Clayton P. A scoring system to screen elderly potential kidney transplant recipients: A simple tool for a complex task. Kidney International. 2015;88(1):5-6.
Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes. American Society of Nephrology Clinical Journal. 2013;8(9):1556-63.
McKercher C, Chan H, Clayton P, McDonald S, Jose M. Dialysis outcomes of elderly Indigenous and non-Indigenous Australians. Nephrology. 2014;19(10):610-6.
Mallett A, Tang W, Clayton P, Stevenson S, McDonald S, Hawley C, et al. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases. Nephrology Dialysis Transplantation. 2014;29(12):2277-86.
Lan PG, Clayton PA, Hyett J, Gillin AG. Measuring blood pressure in pregnancy and postpartum: Assessing the reliability of automated measuring devices. Hypertension in Pregnancy. 2014;33(2):168-76.
Lan P, Johnson D, McDonald S, Boudville N, Borlace M, Badve S, et al. The association between peritoneal dialysis modality and peritonitis. Clin J Am Soc Nephrol. 2014;9(6):1091-7.
Grace B, Kennedy S, Clayton P, McDonald S. Racial disparities in paediatric kidney transplantation. Pediatr Nephrol. 2014;29(1):125-32.
Grace B, Clayton P, Gray N, McDonald S. Socioeconomic differences in the uptake of home dialysis. Clin J Am Soc Nephrol. 2014;9(5):929-35.
Foote C, Clayton P, Johnson D, Jardine M, Snelling P, Cass A. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand dialysis and Transplant Registry (ANZDATA). Am J Kidney Dis. 2014;64(3):359-66.
Clayton P, McDonald S, Snyder J, Salkowski N, Chadban S. External validation of the estimated posttransplant survival score for allocation of deceased donor kidneys in the United States. American Journal of Transplantation. 2014;14(8):1922-6.
Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis. Nephrology Dialysis Transplantation. 2014;29(10):1940-7.
Badve S, Paul S, Klein K, Clayton P, Hawley C, Brown F, et al. The association between body mass index and mortality in incident dialysis patients. PLoS ONE. 2014;9(12):e114897-1-e-13.
Wyld MLR, Clayton PA, Morton RL, Chadban SJ. Anti-coagulation, anti-platelets or no therapy in haemodialysis patients with atrial fibrillation: A decision analysis. Nephrology. 2013;18(12):783-9.
Wyld M, Clayton P, Jesudason S, Chadban S, Alexander S. Pregnancy outcomes for kidney transplant recipients. American Journal of Transplantation. 2013;13(12):3173-82.
Vacher-Coponat H, McDonald S, Clayton P, Loundou A, Allen RDM, Chadban SJ. Inferior early posttransplant outcomes for recipients of right versus left deceased donor kidneys: An ANZDATA registry analysis. American Journal of Transplantation. 2013;13(2):399-405.
Tang W, McDonald S, Hawley C, Badve S, Boudville N, Brown F, et al. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. Kidney International. 2013;83(3):503-10.
Tang W, McDonald S, Hawley C, Badve S, Boudville N, Brown F, et al. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases. Nephrology Dialysis Transplantation. 2013;28(2):455-61.
Tang W, Bose B, McDonald S, Hawley C, Badve S, Boudville N, et al. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. American Society of Nephrology Clinical Journal. 2013;8(5):773-80.
McDonald S, Clayton P. DCD ECD kidneys – Can you make a silk purse from a sow’s ear? American Journal of Transplantation. 2013;13(2):249-50.
Lim W, Clayton P, Wong G, Campbell S, Cohney S, Russ G, et al. Outcomes of kidney transplantation from older living donors. Transplantation. 2013;95(1):106-13.
Krishnasamy R, Badve S, Hawley C, McDonald S, Boudville N, Brown F, et al. Daily variation in death in patients treated by long-term dialysis: comparison of in-center hemodialysis to peritoneal and home hemodialysis. Am J Kidney Dis. 2013;61(1):96-103.
Jiang SH, Roberts DM, Clayton PA, Jardine M. Non-tuberculous mycobacterial PD peritonitis in Australia. Int Urol Nephrol. 2013;45(5):1423-8.
Grace B, Clayton P, Cass A, McDonald S. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney International. 2013;83(1):138-45.
Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study. Perit Dial Int. 2013;33(1):75-85.
Thirugnanasambathan T, Hawley C, Badve S, McDonald S, Brown F, Boudville N, et al. Repeated peritoneal dialysis-associated peritonitis: a multicenter registry study. Am J Kidney Dis. 2012;59(1):84-91.
Tang W, Mohandas J, McDonald S, Hawley C, Badve S, Boudville N, et al. End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA Registry cases. BMC Nephrology. 2012;13(164):1-11.
Ritchie AG, Clayton PA, MacKie FE, Kennedy SE. Nationwide survey of adolescents and young adults with end-stage kidney disease. Nephrology. 2012;17(6):539-44.
Lim W, Dogra G, Chadban S, Campbell S, Clayton P, Cohney S, et al. Lack of impact of donor age on patient survival for renal transplant recipients ≥ 60 years. Transpl Int. 2012;25(4):401-8.
Lim W, Clayton P, Wong G, Dogra G, Budgeon C, Murray K, et al. Association between initial and pretransplant dialysis modality and graft and patient outcomes in live- and deceased-donor renal transplant recipients. Transpl Int. 2012;25(10):1032-40.
Lim W, Chadban S, Clayton P, Budgeon C, Murray K, Campbell S, et al. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients. Clinical Transplantation. 2012;26(4):428-37.
Johnson D, Clayton P, Cho Y, Badve S, Hawley C, McDonald S, et al. Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis. Perit Dial Int. 2012;32(5):516-24.
Grace B, Clayton P, McDonald S. Increases in renal replacement therapy in Australia and New Zealand: Understanding trends in diabetic nephropathy. Nephrology. 2012;17(1):76-84.
Grace B, Clayton P, Cass A, McDonald S. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrology Dialysis Transplantation. 2012;27(11):4173-80.
Clayton P, McDonald S, Chapman J, Chadban S. Mycophenolate versus azathioprine for kidney transplantation: a 15-year follow-up of a randomized trial. Transplantation. 2012;94(2):152-8.
Cho Y, Badve S, Hawley C, McDonald S, Brown F, Boudville N, et al. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study. BMC Nephrology. 2012;13(1):1-9.
Cho Y, Badva S, Hawley C, McDonald S, Brown F, Boudville N, et al. Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study. Nephrology Dialysis Transplantation. 2012;27(5):2028-36.
Chan H, Clayton P, McDonald S, Agar J, Jose M. Risk factors for dialysis withdrawal: An analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008. American Society of Nephrology Clinical Journal. 2012;7(5):775-81.
Boudville N, Kemp A, Clayton P, Lim W, Badve S, Hawley C, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398-405.
Clayton P, McDonald S, Chadban S. Steroids and recurrent IgA nephropathy after kidney transplantation. American Journal of Transplantation. 2011;11(8):1645-9.
Bose B, McDonald S, Hawley C, Brown F, Badve S, Wiggins K, et al. Effect of dialysis modality on survival of hepatitis C-infected ESRF patients. American Society of Nephrology Clinical Journal. 2011;6(11):2657-61.
Yew CT, Talaulikar GS, Falk MC, Clayton P, Drozario J, Brown M. Acute interstitial nephritis secondary to deferasirox causing acute renal injury needing short-term dialysis. Nephrology. 2010;15(3):377.
Jiang SHT, Clayton PA, Maguire A, Talaulikar GS. Validation of the measurement of haemodialysis access flow using a haemoglobin dilution test. Blood Purif. 2011;32(1):48-52.
Clayton P, Singer R. 25-Hydroxyvitamin D levels in prevalent Australian dialysis patients. Nephrology. 2009;14(6):554-9.